{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:08:24Z","timestamp":1791320904857,"version":"4.3.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Glycogen storage disease is a group of disorders primarily characterized by hepatomegaly and fasting hypoglycemia. This group of disorders may also affect the muscle, kidneys, and neurodevelopment. With an overall prevalence of 1\u200a:\u200a20\u200a000, GSDs are disorders that clinicians should diagnose in a timely manner because adequate management can prevent complications, such as neurodevelopmental delay and liver disease [1]. As there are numerous types of GSDs, being able to distinguish one type from another can be overwhelming. In this review, we focus on hepatic GSDs to provide a concise review of clinical presentation, diagnosis, and current management.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>GSDs are considered rare disorders, and one of the main challenges is the delay in diagnosis, misdiagnosis, or under diagnosis. However, with molecular genetic testing now readily available, confirming the diagnosis is no longer as difficult or invasive as it was in the past.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Current therapy for this group of disorders requires maintaining stable glucose levels. Avoiding hypoglycemia, as well as hyperglycemia, is critical in managing these patients. Being able to distinguish the types of GSDs and understanding the specific treatments for each enzymatic defect will optimize patient care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000001158","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:02:38Z","timestamp":1660017758000},"page":"496-502","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":15,"title":["Update on glycogen storage disease: primary hepatic involvement"],"prefix":"10.1097","volume":"34","author":[{"given":"Tiffany L. Freeney","family":"Wright","sequence":"first","affiliation":[{"name":"Division of Pediatric Gastroenterology, Nutrition and Hepatology, Department of Pediatrics, University of Texas Southwestern Medical Center"},{"name":"Children's Medical Center Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis A.","family":"Uma\u00f1a","sequence":"additional","affiliation":[{"name":"Children's Medical Center Dallas"},{"name":"Division of Pediatric Genetics and Metabolism, Department of Pediatrics, University of Texas Southwestern Medical Center, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charina M.","family":"Ramirez","sequence":"additional","affiliation":[{"name":"Division of Pediatric Gastroenterology, Nutrition and Hepatology, Department of Pediatrics, University of Texas Southwestern Medical Center"},{"name":"Children's Medical Center Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"R4-20250730","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10545-014-9785-5","article-title":"Glycogen pathways in disease: new developments in a classical field of medical genetics","volume":"38","author":"Kilimann","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"R5-20250730","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.3390\/nu13113828","article-title":"Glycogen storage disease type Ia: current management options, burden and unmet needs","volume":"13","author":"Derks","year":"2021","journal-title":"Nutrients"},{"key":"R6-20250730","doi-asserted-by":"crossref","first-page":"474","DOI":"10.21037\/atm.2018.10.59","article-title":"Glycogen metabolism and glycogen storage disorders","volume":"6","author":"Kanungo","year":"2018","journal-title":"Ann Transl Med"},{"key":"R8-20250730","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"key":"R9-20250730","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1182\/blood.2019004465","article-title":"Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor","volume":"136","author":"Wortmann","year":"2020","journal-title":"Blood"},{"key":"R11-20250730","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/s13023-020-01573-8","article-title":"Diagnosis of hepatic glycogen storage disease patients with overlapping clinical symptoms by massively parallel sequencing: a systematic review of literature","volume":"15","author":"Beyzaei","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"R12-20250730","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/advances\/nmz092","article-title":"Dietary management of the glycogen storage diseases: evolution of treatment and ongoing controversies","volume":"11","author":"Ross","year":"2020","journal-title":"Adv Nutr"},{"key":"R13-20250730","first-page":"85","article-title":"Safety and efficacy of chronic extended release cornstarch therapy for glycogen storage disease type I","volume":"26","author":"Ross","year":"2016","journal-title":"JIMD Rep"},{"key":"R15-20250730","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med"},{"key":"R16-20250730","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jimd.12339","article-title":"The potential of dietary treatment in patients with glycogen storage disease type IV","volume":"44","author":"Derks","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"R17-20250730","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1007\/s10545-009-1088-x","article-title":"Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet","volume":"32 Suppl 1","author":"Dagli","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"R19-20250730","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1442-200X.2010.03282.x","article-title":"Liver biopsy is an important procedure in the diagnosis of glycogen storage disease type IV","volume":"53","author":"Mizuochi","year":"2011","journal-title":"Pediatr Int"},{"key":"R20-20250730","first-page":"1","article-title":"Liver transplantation for glycogen storage disease type IV","volume":"9","author":"Liu","year":"2021","journal-title":"Front Pediatr"},{"key":"R22-20250730","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00431-019-03499-1","article-title":"Glycogen storage disease type VI: clinical course and molecular background","volume":"179","author":"Aeppli","year":"2020","journal-title":"Eur J Pediatr"},{"key":"R23-20250730","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/genes12081205","article-title":"The Phenotypic and Genetic Spectrum of Glycogen Storage Disease Type VI","volume":"12","author":"Gr\u00fcnert","year":"2021","journal-title":"Genes (Basel)"},{"key":"R24-20250730","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet Med"},{"key":"R26-20250730","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymgme.2007.06.007","article-title":"Glycogen storage disease type IX: high variability in clinical phenotype","volume":"92","author":"Beauchamp","year":"2007","journal-title":"Mol Genet Metab"},{"key":"R27-20250730","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1017\/cjn.2020.18","article-title":"Neurological involvement in glycogen storage disease type IXa due to PHKA2 mutation","volume":"47","author":"Smith","year":"2020","journal-title":"Can J Neurol Sci"},{"key":"R28-20250730","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2005.10.006","article-title":"Hepatic glycogen synthase deficiency: an infrequently recognized cause of ketotic hypoglycemia","volume":"87","author":"Weinstein","year":"2006","journal-title":"Mol Genet Metab"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T18:01:44Z","timestamp":1753898504000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000001158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000001158","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]}}}